Methicillin-Resistant Staphylococcus aureus Colonization or Infection in Canada: National Surveillance and Changing Epidemiology, 1995–2007
The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the incidence and describe the changing epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) colonization or infection in Canadian hospitals from 1995-2007. SETTING: Forty-eight hospitals participating in the Canadian Nosocomial Infection Surveillance Program. DESIGN: Prospective, laboratory-based surveillance for incident cases of MRSA colonization or infection among hospitalized patients. METHODS: Clinical and epidemiologic data were obtained by review of hospital records. Standard criteria were used to determine whether MRSA colonization or infection was present and whether the MRSA strain was healthcare associated or community associated. A representative subset of isolates was characterized by use of pulsed-field gel electrophoresis and staphylococcal cassette chromosome (SCC) mec typing. RESULTS: From 1995 to 2007, a total of 37,169 hospitalized patients were newly identified as either infected or colonized with MRSA, and the overall incidence of both MRSA colonization and MRSA infection increased from 0.65 to 11.04 cases per 10,000 patient-days (P < .001). Of these 37,169 patients, 11,828 (32%) had an MRSA infection, and infection rate increased from 0.36 to 3.43 cases per 10,000 patient-days. The proportion of community-associated MRSA strains increased from 6% to 23% (P < .001). The most common genotype (47% of isolates) was CMRSA-2 (USA100/800); in 2007, CMRSA-10 (USA300) was the second most common strain (27% of isolates), associated with SCCmec type IV. Patients with CMRSA-10 were predominantly from western Canada and were more likely to be children (odds ratio [OR], 10.0 [95% confidence interval {CI}, 7.4-13.4]) and to have infection (OR, 2.3 [95% CI, 1.9-2.7]), especially skin and/or soft tissue infection (OR, 5.9 [95% CI, 5.0-6.9]). CONCLUSIONS: The overall incidence of both MRSA colonization and MRSA infection increased 17-fold in Canadian hospitals from 1995 to 2007. There has also been a dramatic increase in cases of community-associated MRSA infection due to the CMRSA-10 (USA300) clone. Continued surveillance is needed to monitor the ongoing evolution of MRSA colonization or infection in Canada and globally.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This ST belongs to clonal complex 5 (CC5), the leading cause of HA-MRSA infection in Canada [30], as well as CA-MRSA colonization in Canada and the United States [30], [31].”
From Carriage of Methicillin-Resistant Staphylococcus aureus by Wild Urban Norway Rats (Rattus norvegicus) (2014) · cites this paper as [30]
Citations
Cites
Horan, T. C., Andrus, M., & Dudeck, M. A. (2008) · American Journal of Infection Control · doi:10.1016/j.ajic.2008.03.002 · Cited by 6,626 · cited 2×
“4,266 1,136 (27) 2,051 (48) 437 (10) 72 (2) 32(1) 538 (13)”
Canadian Institute for Health Information.
Lalonde, A. (1994) · PubMed · Cited by 4,739
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489 · cited 4×
“14,234 (38) 12,379 (33) 3,509 (9) 6,939 (19)”
InfluentialCosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964 · cited 3×
“229 (14) 409 (25) 396 (24) 425 (26) 160 (10) 9(1) (%) of patients”
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493 · cited 7×
“1,917 (45) 690 (16) 582 (14) 1,096 (26)”
InfluentialMcDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399 · cited 3×
“14,234 (38) 12,379 (33) 3,509 (9) 6,939 (19)”
Oliveira, D. C., & Lencastre, H. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2155-2161.2002 · Cited by 1,343 · cited 2×
“920 (12) 1,269 (16) 2,899 (37) 1,443 (18) 834 (11) 451 (6) P”
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Grundmann, H., Aires-de-Sousa, M., Boyce, J., & Tiemersma, E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68853-3 · Cited by 1,101
Klein, E., Smith, D. L., & Laxminarayan, R. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1312.070629 · Cited by 862 · cited 3×
“4,328 (39) 2,970 (27) 1,587 (14) 2,190 (20)”
Cited by
Nimmo, G. R. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03822.x · Cited by 201
Thurlow, L. R., Joshi, G. S., & Richardson, A. R. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00937.x · Cited by 166
Chua, K., Laurent, F., Coombs, G., Grayson, M. L., & Howden, B. P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq067 · Cited by 159
“The situation in Canada is similar to that in the United States, with USA300 becoming increasingly common [31].”
BackgroundMupB, a New High-Level Mupirocin Resistance Mechanism in Staphylococcus aureus
Seah, C., Alexander, D. C., Louie, L., Simor, A. E., Low, D. E., Longtin, J., & Melano, R. G. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05325-11 · Cited by 166
“The three MRSA strains (designated MUP87, MUP88, and MUP91) included in this study were recovered during surveillance conducted by the Canadian Nosocomial Infection Surveillance Program in 2004 (19, 20).”
BackgroundSelf-citationCrago, B., Ferrato, C., Drews, S. J., Svenson, L. W., Tyrrell, G., & Louie, M. (2012) · Food Microbiology · doi:10.1016/j.fm.2012.04.012 · Cited by 128
Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges
Kern, W. V. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833bcc8a · Cited by 102
Plano, L. R. W., Garza, A. C., Shibata, T., Elmir, S. M., Kish, J. K., Sinigalliano, C. D., Gidley, M. L., Miller, G. A., Withum, K. F., Fleming, L. E., et al. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-5 · Cited by 102
“However, it is highly likely that similar studies with additional pediatric participants would result in the isolation of MRSA [29].”
ResultLongtin, J., Seah, C., Siebert, K., McGeer, A., Simor, A., Longtin, Y., Low, D. E., & Melano, R. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01707-10 · Cited by 84
“spa typing revealed that our clones are consistent with Canadian MRSA epidemiology, so we do not expect a selection bias (4, 18).”
ResultSelf-citationMitchell, R., Taylor, G. D., Rudnick, W., Alexandre, S., Bush, K. J., Forrester, L., Frenette, C. H., Granfield, B., Gravel-Tropper, D., Happe, J., et al. (2019) · Canadian Medical Association Journal · doi:10.1503/cmaj.190361 · Cited by 84
Self-citationXiao, M., Wang, H., Zhao, Y. Y., Mao, L.-L., Brown, M., Yu, Y., O'Sullivan, M. V. N., Kong, F., & Xu, Y. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01375-13 · Cited by 84
“Previous studies have documented several major MRSA clones in different geographic regions, e.g., the HA-MRSA clone ST239-III prevails in most Asian countries (2, 3, 5) and the CA-MRSA clone US300 (CMRSA-10) is prevalent in North America (5, 15, 16).”
BackgroundNichol, K. A., Adam, H. J., Hussain, Z., Mulvey, M. R., McCracken, M., Mataseje, L. F., Thompson, K., Kost, S. E. F., Lagacé-Wiens, P. R. S., Hoban, D. J., et al. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.10.028 · Cited by 81
Self-citationYeung, M., Balma‐Mena, A., Shear, N. H., Simor, A. E., Pope, E., Walsh, S. R., & Mcgavin, M. J. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.10.023 · Cited by 71
Self-citationHimsworth, C. G., Miller, R. R., Montoya, V., Hoang, L., Romney, M. G., Al-Rawahi, G. N., Kerr, T., Jardine, C. M., Patrick, D. M., Tang, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087983 · Cited by 60
Mitevska, E., Wong, B., Surewaard, B. G. J., & Jenne, C. N. (2021) · Pathogens · doi:10.3390/pathogens10040393 · Cited by 58
“First Author, Year MRSA Prevalence Year Region Population Simor et al., 2010 Prevalence (per 10,000 patient days): 1995: 0.36 2007: 3.43 1995–2007 Across Canada Hospital Patients Warshawsky et al., 2000 Prevalence: 37 per 100,000 patients 1997 London, ON Hospital andClinic Patients Sligl et al., 2007 Infection Rate: 3…”
BackgroundInfluentialTadros, M., Williams, V. L., Coleman, B. L., McGeer, A., Haider, S., Lee, C., Iacovides, H., Rubinstein, E., John, M., Johnston, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075171 · Cited by 59
“Place of MRSA acquisition (healthcare facility or community) was ascertained based on available epidemiologic data and using previously published criteria [18].”
MethodSelf-citationMethicillin‐ResistantStaphylococcus aureus: An Update
Durai, R., Ng, P. C., & Hoque, H. (2010) · AORN Journal · doi:10.1016/j.aorn.2009.11.065 · Cited by 63
Prevalence of methicillin-resistant Staphylococcus aureus among university students in Thailand.
Kitti, T., Boonyonying, K., & Sitthisak, S. (2011) · PubMed · Cited by 50
Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada
Nichol, K. A., Adam, H. J., Roscoe, D. L., Golding, G. R., Lagace-Wiens, P. R. S., Hoban, D. J., Zhanel, G. G., on behalf of the Canadian Antimicrobial Resistance Alliance (CARA), Zhanel, G. G., Hoban, D. J., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt026 · Cited by 52
Community-Acquired Methicillin-Resistant Staphylococcus aureus: The New Face of an Old Foe?
Udo, E. E. (2013) · Medical Principles and Practice · doi:10.1159/000354201 · Cited by 52
Li, J., Wang, L., Ip, M., Sun, M., Sun, J., Huang, G., Wang, C., Deng, L., Zheng, Y., Fu, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070602 · Cited by 47
Simor, A. E., Williams, V. L., McGeer, A., Raboud, J., Larios, O. E., Weiss, K., Hirji, Z., Laing, F., Moore, C., & Gravel, D. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/670998 · Cited by 43
“MRSA or VRE were defined as healthcare associated if the initial identification of the organism was more than 48 hours after hospital admission; if the patient had been hospitalized or in a long-term care facility in the previous 12 months; if the patient had an indwelling medical device; or if the patient had had ano…”
BackgroundSelf-citationFaires, M. C., Pearl, D. L., Berke, O., Reid‐Smith, R. J., & Weese, J. S. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-342 · Cited by 43
“Background In Canadian hospitals, the incidence of meticillinresistant Staphylococcus aureus (MRSA) infections and colonization have increased 17-fold from 1995 to 2007 [1] and remains a leading cause for a range of opportunistic infections [1].”
BackgroundNeutrophil Crawling in Capillaries; A Novel Immune Response to Staphylococcus aureus
Harding, M. G., Zhang, K., Conly, J. M., & Kubes, P. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004379 · Cited by 40
High Rates ofStaphylococcus aureusUSA400 Infection, Northern Canada
Golding, G. R., Levett, P. N., McDonald, R. R., Irvine, J. D., Quinn, B., Nsungu, M., Woods, S., Khan, M., Ofner-Agostini, M., Mulvey, M. R., et al. (2011) · Emerging infectious diseases · doi:10.3201/eid1704.100482 · Cited by 38
“2011 Apr; [Epub ahead of print] High Rates of Staphylococcus aureus USA400 Infection, Northern Canada George R. Golding, Paul N. Levett, Ryan R. McDonald, James Irvine, Brian Quinn, Mandiangu Nsungu, Shirley Woods, Mohammad Khan, Marianna Ofner-Agostini, Michael R. Mulvey, and the Northern Antibiotic Resistance Partne…”
InfluentialSelf-citationLesosky, M., McGeer, A., Simor, A. E., Green, K., Low, D. E., & Raboud, J. (2011) · Infection Control and Hospital Epidemiology · doi:10.1086/657945 · Cited by 38
Self-citationTawil, N., Mouawad, F., Lévesque, S., Sacher, E., Mandeville, R., & Meunier, M. (2013) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2013.05.031 · Cited by 38
“Contents lists available at SciVerse ScienceDirect Biosensors and Bioelectronics 0956-56 http://d n Corr E-m journal homepage: www.elsevier.com/locate/bios The differential detection of methicillin-resistant, methicillinsusceptible and borderline oxacillin-resistant Staphylococcus aureus by surface plasmon resonance N…”
BackgroundMethodInfluentialVancomycin Loading Doses: A Systematic Review
Reardon, J., Lau, T. T. Y., & Ensom, M. H. H. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015571163 · Cited by 36
Simor, A. E., Pelude, L., Golding, G. R., Fernandes, R., Bryce, E., Frenette, C. H., Gravel, D., Katz, K. C., McGeer, A., Mulvey, M. R., et al. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.323 · Cited by 34
“Surveillance for MRSA BSI was laboratory based, using previously described methods.(11) Hospitalized patients with a MRSA isolate recovered from at least 1 set of blood cultures were included; patients were included only once (with the initial blood culture isolate).”
BackgroundMethodSelf-citationAmiali, N. M., Golding, G. R., Sedman, J., Simor, A. E., & Ismail, A. A. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.12.016 · Cited by 32
Self-citationChurch, D. L., Chow, B. L., Lloyd, T., & Gregson, D. B. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.09.010 · Cited by 35
“…of MRSA has undergone a marked change in the past 10 years with the worldwide emergence of MRSA as a community pathogen (CA-MRSA) (Boucher and Corey, 2008; Chambers and Deleo, 2009; Chambers, 2001a, 2001b; Deleo et al., 2010; Hiramatsu et al., 1997; Simor et al., 2010; Tristan et al., 2007).”
BackgroundJeong, D., Nguyen, H. N. T., TYNDALL, M. W., & Schreiber, Y. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4842-1 · Cited by 28
Golding, G. R., Quinn, B., Bergstrom, K., Stockdale, D. R., Woods, S., Nsungu, M., Brooke, B., Levett, P. N., Horsman, G. B., McDonald, R. R., et al. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-15 · Cited by 32
Self-citationProgram, T. C. N. I. S., Taylor, G., Gravel, D., Matlow, A., Embree, J., LeSaux, N., Johnston, L., Suh, K. N., John, M., Embil, J., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0118-3 · Cited by 26
Self-citationCaffrey, A. R., & LaPlante, K. L. (2011) · Infection · doi:10.1007/s15010-011-0232-3 · Cited by 28
“healthcare-associated MRSA (HA-MRSA), altering the distribution of attributed exposure and 57 onset, strain characteristics, and predominant infection types [1-12].”
BackgroundMarra, F., Patrick, D. M., Chong, M., McKay, R., Hoang, L., & Bowie, W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00649-12 · Cited by 26
“Strains causing SSTI in Western Canada were more likely to be of the CA-MRSA-10 (USA300) strain type, whereas in Eastern Canada, the strain type was predominately CA-MRSA-2 (USA100/800) (35).”
BackgroundBorgundvaag, B., Ng, W., Rowe, B. H., & Katz, K. C. (2013) · Canadian Journal of Emergency Medicine · doi:10.2310/8000.2013.130798 · Cited by 28
Simor, A. E., Louie, L., Watt, C., Gravel, D., Mulvey, M. R., Campbell, J., McGeer, A., Bryce, E., Loeb, M. B., & Matlow, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01717-09 · Cited by 28
Self-citationDelport, J. A., Mohorovic, I., Burn, S., McCormick, J. K., Schaus, D., Lannigan, R., & John, M. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000285 · Cited by 23
Savage, R. D., Fowler, R. A., Rishu, A. H., Bagshaw, S. M., Cook, D., Dodek, P., Hall, R., Kumar, A., Lamontagne, F., Lauzier, F., et al. (2016) · CMAJ Open · doi:10.9778/cmajo.20160074 · Cited by 32
Lee, H., Kim, S., Choi, C. W., Seo, H. K., Shin, M. J., Bok, J., Cho, J. E., Kim, C. J., Shin, J., Kim, T. S., et al. (2014) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.04.003 · Cited by 25
Kim, J., Ferrato, C., Golding, G. R., Mulvey, M. R., Simmonds, K., Svenson, L. W., Keays, G., Chui, L., Lovgren, M., & Louie, M. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810002128 · Cited by 25
“Our findings are similar to earlier studies where CA-MRSA strains tend to infect younger patients with fewer medical comorbidities [12, 24, 27], and HA-MRSA strains are more likely to infect older patients with prolonged hospitalizations and antibiotic exposures [15, 28, 29].”
BackgroundResultSelf-citationRahman, S., & Das, A. K. (2021) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10287-9 · Cited by 22
Rose-Martel, M., Kulshreshtha, G., Berhane, N. A., Jodoin, J., & Hincke, M. T. (2017) · Scientific Reports · doi:10.1038/srep45980 · Cited by 20
Rieck, B., Bates, D., Zhang, K., Escott, N. G., Mougenot, C., Pichardo, S., & Curiel, L. (2014) · Medical Physics · doi:10.1118/1.4875692 · Cited by 20
Rubin, J. E., & Chirino‐Trejo, M. (2011) · Zoonoses and Public Health · doi:10.1111/j.1863-2378.2011.01392.x · Cited by 19
“The high prevalence of iCR described in the present study, particularly among canine isolates and human MSSA, highlights the potential impact of this phenotype in our region.”
BackgroundInfluentialMatlow, A., Forgie, S. E. D., Pelude, L., Embreé, J., Gravel, D., Langley, J. M., Saux, N. L., MOORE, D. L., Mounchili, A., Mulvey, M. R., et al. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31825c48a0 · Cited by 23
“001 CMRSA3/6 (ST241; ST239; CC8) 14 (14) 10 (6) 8 (2) 32 (5) — — CMRSA4 (USA200; ST36) 9 (9) 5 (3) 5 (1) 19 (3) — — CMRSA5 (USA500; ST8) 6 (6) 1 (1) 4 (1) 11 (2) — — CMRSA7 (USA400; ST1; CC1) 3 (3) 19 (12) 102 (24) 124 (18) 28.”
MethodSelf-citationRose-Martel, M., & Hincke, M. T. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.008 · Cited by 16
Li, V. W. T., Chui, L., Simmonds, K., Nguyen, T., Golding, G. R., Yacoub, W., Ferrato, C., & Louie, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00505-14 · Cited by 16
Wang, B., Jessamine, P. G., Desjardins, M., Toye, B., & Ramotar, K. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.09.014 · Cited by 16
Williams, V. L., Simor, A. E., Kiss, A., McGeer, A., Hirji, Z., Larios, O. E., Moore, C., & Weiss, K. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.01.024 · Cited by 15
“National surveillance for AROs in Canada has been conducted by the Canadian Nosocomial Infection Surveillance Program, providing incidence data [1–4], but the number of participating hospitals is relatively small.”
BackgroundMethodSelf-citationHolmes, J., & Williams, M. D. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2010.08.003 · Cited by 13
Genotyping Approaches for Identification and Characterization of Staphylococcus aureus
Al‐Obaidi, M. M. J., Suhaili, Z., & Desa, M. N. M. (2018) · InTech eBooks · doi:10.5772/intechopen.75969 · Cited by 18
“Previous studies stated the reproducibility of PFGE is considered high due to the standardization of protocols [77], allowing national and international surveillance systems [78], and standard interpretation guidelines to investigate the emergence of bacterial species particularly S.”
Guthrie, J. L., Teatero, S., Hirai, S., Fortuna, A., Rosen, D., Mallo, G. V., Campbell, J., Pelude, L., Golding, G. R., Simor, A. E., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa147 · Cited by 13
Self-citationHaseeb, A., Alqurashi, M. K., Althaqafi, A. S., Alsharif, J. M., Faidah, H. S., Bushyah, M., Alotaibi, A. M. F., Elrggal, M. E., Mahrous, A. J., Abuhussain, S. S. A., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11030409 · Cited by 12
Bush, K. J., Leal, J. R., Fathima, S., Li, V. W. T., Vickers, D., Chui, L., Louie, M., Taylor, G. D., & Henderson, E. (2015) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-015-0076-1 · Cited by 12
“USA300/CMRSA10 clones are becoming more common in the healthcare setting [3].”
BackgroundInfluentialPulsed-Field Gel Electrophoresis of Staphylococcus aureus
Golding, G. R., Campbell, J., Spreitzer, D., & Chui, L. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2599-5_8 · Cited by 12
Self-citationTadros, M., Williams, V. R., Plourde, S., Callery, S., Simor, A. E., & Vearncombe, M. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.07.016 · Cited by 11
Self-citationInvasive CA-MRSA in northwestern Ontario: a 2-year prospective study.
Kirlew, M., Rea, S., Schroeter, A., Makahnouk, D., Hamilton, M., Brunton, N. M., Muileboom, J., Schreiber, Y., Saginur, R., & Kelly, L. (2014) · PubMed · Cited by 10
Lévesque, S., Bourgault, A., Galarneau, L.-A., Moisan, D., Doualla‐Bell, F., & Tremblay, C. L. (2014) · Epidemiology and Infection · doi:10.1017/s095026881400209x · Cited by 10
“We have also found, as have others, that CA-MRSA bacteraemias were most frequently secondary to skin and soft tissue infections [9, 26, 27], and commonly associated with intravenous”
ResultHarris, L., Potashman, M. H., Stokes, M., Liu, J., & Lawrence, R. (2016) · Infection and Drug Resistance · doi:10.2147/idr.s93112 · Cited by 10
Pathogenesis of Staphylococcus aureus in Humans
Lu, T., & DeLeo, F. R. (2015) · Wiley eBooks · doi:10.1002/9781118644843.ch39 · Cited by 11
Ugarte-Torres, A., Chú, Á., Read, R., MacDonald, J. C., Gregson, D. B., Louie, T., DeLongchamp, J. Z., Ward, L., McClure, J., Zhang, K., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178557 · Cited by 10
“Community-acquired strains of methicillin-resistant Staphylococcus aureus (CA-MRSA) have been recognized over the last decade with increasing frequency among patients in ambulatory and hospital settings throughout Canada [1] and the United States.”
Wilmer, A., Lloyd-Smith, E., Romney, M., Hoang, L., Hull, M., & Champagne, S. (2011) · Infection Control & Hospital Epidemiology · doi:10.1086/662714 · Cited by 7
“Conversely, a recent epidemiological study of 48 Canadian hospitals identified only limited nosocomial CA-MRSA cases.(2) We evaluated the epidemiology of hospital-onset USA300 colonization or infection within 2 urban hospitals in Vancouver, Canada, over a 1-year period.”
BackgroundInfluentialMcClure, J., & Zhang, K. (2017) · Genome Announcements · doi:10.1128/genomea.00461-17 · Cited by 7
Bartoszko, J. J., Mertz, D., Thabane, L., & Loeb, M. B. (2018) · Systematic Reviews · doi:10.1186/s13643-018-0804-8 · Cited by 6
“The Canadian Nosocomial Infection Surveillance Program reported an increase in hospital admissions for SSTI due to methicillin-resistant Staphylococcus aureus (MRSA) from 24 to 37% between 1994 and 2007 [9].”
BackgroundSelf-citationBader, M. S., Twells, L., & Hawboldt, J. (2011) · Southern Medical Journal · doi:10.1097/smj.0b013e3182387365 · Cited by 5
Grünewald, T., Lindner, M., Weiß, S., Ruf, I., Treutler, T., Ruf, B., & Beige, J. (2013) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2013.02.005 · Cited by 5
“, carriage) are important clinical features (Brugnaro et al., 2009; Lederer et al., 2007; Saxena et al., 2002, 2004; Simor et al., 2010; Johnson et al., 2006; Lentino et al., 2000).”
BackgroundImmunization as a tool to combat antimicrobial resistance
Spika, J. S., & Rud, E. (2015) · Canada Communicable Disease Report · doi:10.14745/ccdr.v41is5a02 · Cited by 5
Bruzzese, S., Bush, K. J., Leal, J. R., KIM, J., Vickers, D., Rusk, A., Fathima, S., Li, V., Chui, L., Louie, M., et al. (2016) · Epidemiology and Infection · doi:10.1017/s0950268816000376 · Cited by 5
“younger populations with fewer comorbidities and more likely to present with skin and soft tissue infections [10, 12].”
BackgroundResultInfluentialHigh rate of Staphylococcus aureus oropharyngeal colonization in children
Pereira, M. F. B., Mimiça, M. J., Carvalho, R. D. L. B., Scheffer, D. K., & Berezin, E. N. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.11.025 · Cited by 5
Beserra, A., Pichardo, S., Kisselgoff, D., Peeva, V., & Curiel, L. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1663944 · Cited by 4
Yoshinaga, J. T. M. (2014) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000172 · Cited by 3
“MRSA colonization was assumed to be present in the absence of clinical signs and symptoms [8].”
BackgroundComparison of Dog and Rabbit Plasmas in the Tube Coagulase Test for Staphylococcus Aureus
Rubin, J. E., Bayly, M., & Chirino‐Trejo, M. (2010) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/104063871002200521 · Cited by 2
“aureus (MRSA) in people and animals have raised awareness in the veterinary community about this potential pathogen.(6,7) Staphylococcus aureus is identified using a number of standard biochemical tests, including the tube coagulase test, typically using rabbit plasma.”
BackgroundZuberi, D. M., Ptashnick, M., Collet, J. C., Lau, T. T. Y., Mirzanejad, Y., & Thomas, É. (2015) · Health Sociology Review · doi:10.1080/14461242.2015.1004799 · Cited by 2
“The threat of HCAIs in Canada has rapidly become more severe, and is poised to become an even more serious threat to patient safety and the healthcare system (Gravel et al., 2009b; Simor et al., 2010).”
BackgroundMcClure, J., & Zhang, K. (2019) · Microbiology Resource Announcements · doi:10.1128/mra.00404-19 · Cited by 3
McClure, J., & Zhang, K. (2019) · Microbiology Resource Announcements · doi:10.1128/mra.00356-19 · Cited by 1
Short, C. T., Mietchen, M. S., & Lofgren, E. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051500 · Cited by 1
“32 [9] Proportion of colonized admissions that have bacteremia”
BackgroundRubin, J. E. (2011) · University Library - University of Saskatchewan (University of Saskatchewan)
Xu, W., Zhou, Q., Yang, C., Yao, H., & Xu, J. (2012) · Physics Procedia · doi:10.1016/j.phpro.2012.05.198
In Vivo Imaging of Neutrophil Responses to Localized S. aureus Infection
Harding, M. G. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.5072/prism/26670
Arshad, S., Shoyinka, A., Perri, M. B., Moreno, D., Jacobsen, G., & Zervos, M. (2013) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318298b81c
Locke, T. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-3210
“I would especially like to thank AMMI Canada and the University Of Ottawa Department of Epidemiology for their financial support which made my trip to present at the conference possible.”
BackgroundMethodInfluentialKim, J. D. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/25388
Epidemiology of Nosocomial Pneumonia in Adults Hospitalized in Canadian Acute Care Facilities
Johnston, B. M. (2011) · TSpace (University of Toronto)
Jeong, D. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-2859
Nakaminami, H. (2026) · Antibiotics · doi:10.3390/antibiotics15100971
“In Canada, the historically dominant USA100/800 lineage remains prevalent, though USA300 has increased in both community and healthcare settings [44,49,50,63].”
Metadata
- Authors
- Simor, A. E., Gilbert, N. L., Gravel, D., Mulvey, M. R., Bryce, E., Loeb, M., Matlow, A., McGeer, A., Louie, L., Campbell, J., & Program, C. N. I. S.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- Hamilton Health Sciences (CA)
- Vancouver General Hospital (CA)
- Public Health Agency of Canada (CA)
- Mount Sinai Hospital (CA)
- Corresponding author
- Simor, Andrew E.
- Venue
- Infection Control & Hospital Epidemiology
- Publisher
- Cambridge University Press (CUP)
- Published
- 2010-04
- Volume
- 31
- Issue
- 4
- Pages
- 348-356
- ISSN
- 0899-823X (ISSN-L)
- 1559-6834
- OpenAlex
- W2110116001
- Cited by
- 87
- References
- 35
- Citations by year
- 2026: 1 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 9 · 2014: 9 · 2013: 14 · 2012: 10
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Infection Control and Hospital Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Public Health Agency
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- methicillin-resistant Staphylococcus aureus, MRSA colonization, MRSA infection, nosocomial infections, community-acquired MRSA, healthcare-associated MRSA, epidemiology, incidence trends, SCCmec typing, USA300, USA100, pulsed-field gel electrophoresis, skin and soft tissue infections, Canadian hospitals, Canada, children, antimicrobial resistance
- MeSH terms
- Canada, Cross Infection, Hospitals, Hospitals, Pediatric, Hospitals, Teaching, Humans, Population Surveillance, Staphylococcal Infections, Incidence, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.